Inventor

Guy J. Laidig

Inventor
Menlo Park, CA, US

Overview

35→
Patents
2007–2020
Patent span
Human necessities
Primary field (CPC A)

Patents· 35 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes21%
C07DHeterocyclic compounds13%
Y02ATechnologies for adaptation to climate change8%
A61BDiagnosis2%
A61NElectrotherapy2%
A62CFire-fighting2%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,793,535Heterocyclic glutaminase inhibitors202010,150,794Compounds for enzyme inhibition20189,938,267Heterocyclic inhibitors of glutaminase20189,657,058'Compounds for enzyme inhibition'20179,205,125'Compounds for enzyme inhibition'20159,205,126'Compounds for enzyme inhibition'20159,205,124'Compounds for enzyme inhibition'20158,921,324'Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides'20148,921,583'Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides'20148,865,718'Heterocyclic inhibitors of glutaminase'20148,765,745'Compounds for enzyme inhibition'20148,735,441'Compounds for enzyme inhibition'20148,716,322'Compounds for enzyme inhibition'20148,609,654'Compounds for enzyme inhibition'20138,604,016'Heterocyclic inhibitors of glutaminase'20138,431,571'Compounds for enzyme inhibition'20138,367,617'Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides'20138,357,683'Compounds for enzyme inhibition'20138,324,174'Compounds for enzyme inhibition'20128,207,127'Compounds for enzyme inhibition'20128,207,124'Compounds for enzyme inhibition'20128,207,125'Compounds for enzyme inhibition'20128,207,126'Compounds for enzyme inhibition'20128,207,297'Compounds for enzyme inhibition'20128,198,270'Compounds for proteasome enzyme inhibition'20128,129,346'Compounds for enzyme inhibition'20128,088,741'Compounds for enzyme inhibition'20128,080,545'Compounds for enzyme inhibition'20118,080,576'Compounds for enzyme inhibition'20117,691,852'Compounds for enzyme inhibition'20107,687,456'Compounds for enzyme inhibition'20107,569,580'Heterotricyclic compounds for use as HCV inhibitors'20097,491,704'Compounds for enzyme inhibition'20097,417,042'Compounds for enzyme inhibition'20087,232,818'Compounds for enzyme inhibition'2007

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2007–2018Based in Menlo Park, CA, US· patent location history
2010–2018Patents assigned to ONYX THERAPEUTICS INC (25)· patent assignee history
2011–2014Patents assigned to LAIDIG GUY J (14)· patent assignee history
2011–2013Patents assigned to SMYTH MARK S (12)· patent assignee history
2011–2014Patents assigned to SHENK KEVIN D (5)· patent assignee history
2013–2020Patents assigned to CALITHERA BIOSCIENCES INC (4)· patent assignee history
2013–2020Based in Woodside, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
ONYX THERAPEUTICS INC252010–2018
LAIDIG GUY Jself142011–2014
SMYTH MARK S122011–2013
SHENK KEVIN D52011–2014
CALITHERA BIOSCIENCES INC42013–2020
Locations
LocationPatentsSpan
Menlo Park, California, US312007–2018
Woodside, California, US42013–2020